Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: Regulation by lipoxin A4 1

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 950-956

  Feng, Zuohua ^a,d   Godfrey, Henry P ^a   Mandy, Szabolcs ^a   Strudwick, Stephen ^a   Lin, King Teh ^b   Heilman, Edward ^c   Wong, Patrick Y K ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYICOSATETRAENOIC ACID; LEUKOTRIENE B4; LIPOXIN; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT; 5 (3 CARBOXYBENZOYL) 2 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]HYDROCINNAMIC ACID; 5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; 7 [3 (4 ACETYL 3 METHOXY 2 PROPYLPHENOXY)PROPOXY] 3,4 DIHYDRO 8 PROPYL 2H 1 BENZOPYRAN 2 CARBOXYLIC ACID; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXIN B; TOMELUKAST; TUBERCULIN;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GUINEA PIG; MALE; SKIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; INTRADERMAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GUINEA PIGS; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE B4; LIPOXINS; MALE; SKIN;

EID: 0030302489     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. BACON, K. B., CAMP, R. D. R., CUNNINGHAM, F. M. AND WOOLLARD, P. M.: Contrasting in vitro lymphocyte chemotactic activity of hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Br. J. Pharmacol. 95: 966-974, 1988.
2. BARR, R. M., BRAIN, S., CAMP, R. D. R., CILLIERS, J., GREAVES, M. W., MALLET, A. I. AND MISCH, K.: Levels of arachidonic acid and its metabolites in the skin of allergic and irritant contact dermatitis. Br. J. Dermatol. 111: 23-28, 1984.
3. 4 and the role of polymorphonuclear leukocytes. Inflammation 6: 189-200, 1982.
4. 4: A mediator of vascular permeability. Br. J. Pharmacol. 72: 483-486, 1981.
5. 4. Br. J. Pharmacol. 80: 497-502, 1983.
6. 4 in the immune system. Int. J. Immunopharmacol. 14: 441-449, 1992.
7. CONNERS, M. S., SCHWARTZMAN, M. L., QUAN, X., HEILMAN, E., CHAUHAN, K., FALCK, J. R. AND GODFREY, H. P.: Enhancement of delayed hypersensitivity inflammatory reactions in guinea pig skin by 12(R)-hydroxy-5,8,14-eicosatrienoic acid. J. Invest. Dermatol. 104: 47-51, 1995.
8. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92: 75-82, 1993.
9. 4 binding sites on guinea pig lung macrophages. J. Pharmacol. Exp. Ther. 247: 1199-1203, 1988.
10. CUNNINGHAM, F. M. AND WOOLLARD, P. M.: 12(R)-hydroxy-5,8,10,14-eicosaenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro. Prostaglandins 34: 71-78, 1987.
11. DVORAK, H. F., GALLI, S. J. AND DVORAK, A. M.: Cellular and vascular manifestations of cell-mediated immunity. Hum. Pathol. 17: 122-137, 1986.
12. 4 from leukocyte membrane preparations by 12(R)- and 12(S)-hydroxyeicosatetraenoic acid. Biochim. Biophys. Acta 917: 406-410, 1987.
13. 4 in inflammation. Crit. Rev. Immunol. 10: 1-12, 1990.
14. 4-induced neutrophil chemotaxis in cavine dermis. Inflammation 13: 601-605, 1989.
15. 4 antagonist have differential effects on granulocyte diapedesis in the guinea pig dermis. Chirality 4: 353-355, 1992.
16. 4. J. Exp. Med. 159: 1027-1041, 1984a.
17. 4. J. Allergy Clin. Immunol. 74: 373-377, 1984b.
18. 4-induced inflammation in the hamster cheek pouch. Acta Physiol. Scand. 137: 571-572, 1989.
19. HENDERSON, W. R., JR.: The role of leukotrienes in inflammation. Ann. Intern. Med. 121: 684-697, 1994.
20. 4-induced neutrophil activation by LY-223982. J. Pharmacol. Exp. Ther. 263: 1009-1014, 1992.
21. JESTY, J. AND GODFREY, H. P.: Parlin, a general microcomputer program for parallel-line analysis of bioassays. Am. J. Clin. Pathol. 85: 485-489, 1986.
22. 4-induced neutrophil functions. Prostaglandins 44: 261-275, 1992.
23. KRISTENSEN, M., JINQUAN, T., THOMSEN, M. K., ZACHARIAE, C., PALUDAN, K., AHNFELT-RØNNE, I., MATSUSHIMA, K., THESTRUP-PEDERSEN, I. AND LARSEN, C. G.: ETH615, a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production of and biological responses towards interleukin-8. Exp. Dermatol. 2: 165-170, 1993.
24. LARSEN, C. G., THOMSEN, M. K., GESSER, B., THOMSEN, P. D., DELEURAN, B. W., NOWAK, J., SKØDT, V., THOMSEN, H. K., DELEURAN, M., THESTRUP-PEDERSEN, K., HARADA, A., MATSUSHIMA, K. AND MENNÉ, T.: The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J. Immunol. 155: 2151-2157, 1995.
25. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin. Sci. 77: 195-203, 1989.
26. 4 induces hyperadhesiveness in human endothelial cells for neutrophils. Blood 82: 948-953, 1993.
27. + T lymphocytes. J. Pharmacol. Exp. Ther. 276: 958-967, 1996.
28. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183: 137-146, 1996.
29. MANDY, S., FENG, Z., CANFIELD, L. S., MANDY, K, QUAN, X., ROWEHL, R. A., KHAN, M. Y., AKIYAMA, S. K. AND GODFREY, H. P.: Inhibition of expression of delayed hypersensitivity by neutralizing monoclonal anti-T cell fibronectin antibody. Immunology 83: 582-588, 1994.
30. MANOLIOS, N., BAKIERA, B., GECZY, C. L. AND SCHREIBER, L.: Arachidonic acid metabolites in normal and autoimmune mice do not influence lyphocyte-high endothelial venule interactions. Immunol. Cell Biol. 69: 39-46, 1991.
31. MARFAT, A. AND COREY, E. J.: Synthesis of leukotrienes. Adv. Prostaglandin Thromboxane Leukotriene Res. 14: 155-228, 1985.
32. MCMILLAN, R. M. AND FOSTER, S. J.: Leukotrienes and inflammation. Agents Actions 24: 114-119, 1988.
33. 4 receptor. J. Immunol. 147: 3096-3103, 1991.
34. 4-induced hyperadhesiveness of endothelial cells for neutrophils: Relation to CD54. Clin. Exp. Immunol. 90: 300-304, 1992.
35. 4 induced hyperadhesiveness of endothelial cells for neutrophils. J. Immunol. 152: 262-269, 1994.
36. 4. Proc. Natl. Acad. Sci. U.S.A. 81: 3501-3505, 1984.
37. 4: Implications for the regulation of inflammatory responses. Br. J. Pharmacol. 110: 423-427, 1993.
38. 4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects. J. Pharmacol. Exp. Ther. 246: 732-738, 1988.
39. QUAN, X. AND GODFREY, H. P.: Induction of endothelial adhesion molecules by T cell fibronectin (FN). FASEB J. 8: A135, 1994.
40. 4 induced immunoregulation. J. Immunol. 139: 513-517, 1987.
41. 2. J. Lipid Med. 6: 175-181, 1993.
42. SERHAN, C. N.: Lipoxins: Eicosanoids carrying intra- and intercellular messages. J. Bioenerg. Biomemb. 23: 105-122, 1991.
43. SERHAN, C. N.: Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1212: 1-25, 1994.
44. 4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32: 6313-6319, 1993.
45. 4 receptor in human myeloid cells. Eur. J. Pharmacol. 244: 161-173, 1993.
46. WALDMAN, J. S., MARCUS, A. J., SOTER, N. A. AND LIM, H. W.: Cutaneous inflammation: effects of hydroxy acids and eicosanoid pathway inhibitors on vascular permeability. J. Invest. Dermatol. 92: 112-116, 1989.
47. WALLENSTEIN, S., ZUCKER, C. L. AND FLEISS, J. L.: Some statistical methods useful in circulation research. Circ. Res. 47: 1-9, 1980.